SUITE 400 ,WILMINGTON,

Enovis to Host First Quarter 2024 Results Conference Call on May 2nd

Retrieved on: 
Wednesday, April 17, 2024
International, ENOV

Wilmington, DE, April 17, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2024 financial results on Thursday, May 2, 2024 at 8:00 a.m. Eastern Time and issue an earnings press release earlier that morning.

Key Points: 
  • Wilmington, DE, April 17, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2024 financial results on Thursday, May 2, 2024 at 8:00 a.m. Eastern Time and issue an earnings press release earlier that morning.
  • A presentation related to the call will be available on www.enovis.com in the “Investors” section.
  • Investors can access the live webcast via a link on the Enovis website.
  • A link to a replay of the call will also be available on the Enovis website later that day.

Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Retrieved on: 
Thursday, March 28, 2024
Conference, ENOV, Event

Wilmington, DE, March 28, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV) ("Enovis" or the "Company"), an innovation-driven, medical technology growth company, today announced that management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference.

Key Points: 
  • Wilmington, DE, March 28, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV) ("Enovis" or the "Company"), an innovation-driven, medical technology growth company, today announced that management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference.
  • The presentation is scheduled to begin at 3:45 p.m. Eastern Time on Tuesday, April 9, 2024.
  • A link to the live audio webcast, as well as a replay of this event, will be available on the Company’s website under the Investors tab at Events and Presentations.

Enovis Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, February 22, 2024
Acquisition, International, EGX, Investment, ENOV, Growth, Foot, Webcast, P&R, Research, Pharmaceutical industry

Wilmington, DE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- —Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023.

Key Points: 
  • Wilmington, DE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- —Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023.
  • Enovis’ fourth-quarter net sales of $455 million grew 11% from the same quarter in 2022, including 8% organic growth.
  • Fourth quarter results reflect continued execution in P&R, above-market growth in Recon, and the impact of recent acquisitions.
  • Enovis’ full year 2023 net sales of $1.7 billion grew 9% year over year, including 8% organic growth.

Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting

Retrieved on: 
Monday, February 12, 2024
Acquisition, Standard, Comfort, ENOV, Surgeon, Knee pain, DJO, Vitamin E, ROAM, Augmented reality, Elective surgery, Deformity, Patient, Longevity, AAOS, Pressure, American Academy

WILMINGTON, DE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, will showcase its latest technologies across the orthopedic care continuum at the American Academy of Orthopedic Surgeons Annual Meeting 2024.

Key Points: 
  • WILMINGTON, DE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, will showcase its latest technologies across the orthopedic care continuum at the American Academy of Orthopedic Surgeons Annual Meeting 2024.
  • In addition, the Company will present itself as a newly integrated company following the acquisition of orthopedic leader LimaCorporate S.p.A (“Lima”).
  • In our Surgical business, the addition of Lima brings great technologies, capabilities and a product portfolio with demonstrated clinical excellence around the world.
  • Visit AAOS booth #1827 or www.enovis.com to learn how Enovis is developing innovative medical technology that continues to revolutionize the orthopedic industry.

Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Retrieved on: 
Wednesday, February 7, 2024
Recon, ENOV, Canaccord Genuity, Event, Conference

Wilmington, DE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that Brady Shirley, President and COO, Ben Berry, CFO, and Louis Vogt, Group President Recon will present at the Canaccord Genuity Musculoskeletal Conference.

Key Points: 
  • Wilmington, DE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that Brady Shirley, President and COO, Ben Berry, CFO, and Louis Vogt, Group President Recon will present at the Canaccord Genuity Musculoskeletal Conference.
  • The presentation is scheduled to begin at 5:30pm p.m.
  • ET (2:30 p.m. PT) on Monday, February 12, 2024.
  • A link to the live audio webcast, as well as a replay of this event, will be available on the company’s website at Events and Presentations.

Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting

Retrieved on: 
Monday, January 29, 2024
ACFAS, Foot, MIS, Deformity, Acquisition, Surgeon, DJO, American College, ENOV

WILMINGTON, DE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced it will showcase the latest technologies from its Global Foot and Ankle business at the American College of Foot & Ankle (ACFAS) annual meeting in Tampa, Fla., from February 1-4, 2024.

Key Points: 
  • WILMINGTON, DE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced it will showcase the latest technologies from its Global Foot and Ankle business at the American College of Foot & Ankle (ACFAS) annual meeting in Tampa, Fla., from February 1-4, 2024.
  • “With a commitment to advancing technology and improving user experience, we are proud to share our newest technologies at this year’s meeting,” stated Gary Justak, President and General Manager of Enovis™ Foot and Ankle.
  • Additionally, Enovis will be introducing the all new EF1 External Fixation product line, complimenting the flagship DynaNail® and DynaClip™ offerings in the hindfoot segment.
  • Enovis will also highlight products from its foot and ankle continuum of care, including the following products from its subsidiary DJO, LLC:

Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd

Retrieved on: 
Friday, January 26, 2024
International, ENOV

A presentation related to the call will be available on www.enovis.com in the “Investors” section.

Key Points: 
  • A presentation related to the call will be available on www.enovis.com in the “Investors” section.
  • Investors can access the live webcast via a link on the Enovis website.
  • For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call.
  • A link to a replay of the call will also be available on the Enovis website later that day.

Enovis Introduces the DonJoy ROAM™ OA Knee Brace

Retrieved on: 
Thursday, January 25, 2024
Knee pain, Patient, Osteoarthritis, Knee, ROAM, Slim, Proprioception, Environment, Skin, Love, OA, Pressure, Pain, DJO, ENOV, Dentistry

WILMINGTON, DE, Jan. 25, 2024 (GLOBE NEWSWIRE) --  Enovis™ Corporation (“Enovis” or the “Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, announced today that its DJO, LLC subsidiary has launched its new DonJoy® ROAM™ OA knee brace for patients with osteoarthritis or other knee pain and instability.

Key Points: 
  • WILMINGTON, DE, Jan. 25, 2024 (GLOBE NEWSWIRE) --  Enovis™ Corporation (“Enovis” or the “Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, announced today that its DJO, LLC subsidiary has launched its new DonJoy® ROAM™ OA knee brace for patients with osteoarthritis or other knee pain and instability.
  • Designed for conservative care, preparation for surgery, or for postoperative knee protection, ROAM OA is ideal for a wide range of patients who want to maintain or increase activity.
  • “ROAM OA represents the next generation of unloader knee braces for active patients with pain due to osteoarthritis or other causes," said Terry Ross, Group President of Enovis Prevention & Recovery.
  • “It’s effective and easy for patients to use and easy for providers to prescribe, even for patients who would otherwise need a customized device.”
    For more information about the ROAM OA knee brace, visit www.enovis.com/roamoa .

Enovis Completes Acquisition of LimaCorporate S.p.A

Retrieved on: 
Wednesday, January 3, 2024
Acquisition, Motion, Growth, 3D, ENOV

WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) an innovation-driven, medical technology growth company, today announced that it closed the acquisition of LimaCorporate S.p.A. (“Lima”), a privately held global orthopedic leader focused on restoring motion through an innovative portfolio of implant solutions.

Key Points: 
  • WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) an innovation-driven, medical technology growth company, today announced that it closed the acquisition of LimaCorporate S.p.A. (“Lima”), a privately held global orthopedic leader focused on restoring motion through an innovative portfolio of implant solutions.
  • Lima strengthens Enovis’ position in the global orthopedic reconstruction market with a complementary portfolio of proven surgical solutions and technologies, which will accelerate global growth and margin expansion.
  • “We are excited to welcome Lima's talented team to Enovis.
  • The combination brings Enovis’ recon segment to $1 billion in revenues and creates a fast-growing innovator in the global orthopedic reconstruction market.

Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Thursday, December 28, 2023
PST, EST, Event, Conference, ENOV

Wilmington, DE, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with investors at the 42nd Annual J.P. Morgan Healthcare Conference with a presentation scheduled for Monday, January 8th, 2024, at 9:45 a.m. PST (12:45 p.m. EST).

Key Points: 
  • Wilmington, DE, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with investors at the 42nd Annual J.P. Morgan Healthcare Conference with a presentation scheduled for Monday, January 8th, 2024, at 9:45 a.m. PST (12:45 p.m. EST).
  • A link to the live audio webcast, as well as a replay of this event, will be available on the company’s website at Events and Presentations.